Clinical Trials
4
Active:0
Completed:4
Trial Phases
4 Phases
Phase 1:1
Phase 2:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (25.0%)Phase 1
1 (25.0%)Phase 2
1 (25.0%)Phase 4
1 (25.0%)An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration
Phase 1
Completed
- Conditions
- Neovascular Age-Related Macular Degeneration
- Interventions
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2018-09-24
- Lead Sponsor
- Retinal Consultants of Arizona
- Target Recruit Count
- 30
- Registration Number
- NCT02591914
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)
Phase 4
Completed
- Conditions
- Neovascular Age Related Macular Degeneration
- Interventions
- First Posted Date
- 2013-05-27
- Last Posted Date
- 2017-10-04
- Lead Sponsor
- Retinal Consultants of Arizona
- Target Recruit Count
- 60
- Registration Number
- NCT01863199
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
Topcon Endpoint Management
Not Applicable
Completed
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2012-11-26
- Last Posted Date
- 2014-03-20
- Lead Sponsor
- Retinal Consultants of Arizona
- Target Recruit Count
- 10
- Registration Number
- NCT01732614
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Phase 2
Completed
- Conditions
- Macular EdemaDiabetes Mellitus
- Interventions
- Drug: Steroid plus NSAID eye drop combination therapy
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Retinal Consultants of Arizona
- Target Recruit Count
- 40
- Registration Number
- NCT01673191
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
News
No news found